Igenomix is closely monitoring news and reports from the Centers for Disease Control (CDC), World Health Organization (WHO) and local government authorities regarding the new coronavirus disease: COVID-19. We are taking all necessary precautions to ensure the timeliness and quality of the tests and services we offer.
The health and safety of our employees, as well as the integrity of test samples, are of utmost importance. At this time, we are experiencing minimal delays in test results. However, as the situation is rapidly evolving, it is difficult to predict how the COVID-19 outbreak could affect our employees and workflows.
Samples are received from the clinic without air exposure. Upon receipt, samples are processed and maintained under CLIA Regulations and State Guidelines. We also understand that there may be concerns surrounding the shipment of samples due to travel bans recently implemented for containment of COVID-19. We are not aware of any issues regarding shipping samples at this time, however, our ability to ship samples depends on the protocols of our couriers, who also adhere to guidelines from government authorities.
We appreciate your cooperation and collaboration.
